Dark Light
, ,

AMI Eyes Skin Booster – 2ml

Availability:

$ 35.24

AMI Eyes Polynucleotide Skin Booster is a professional injectable developed for use in the periocular region, where the skin is thinner, more delicate, and often shows early signs of textural change and dehydration. It is positioned for practitioners seeking a targeted skin quality treatment for the under-eye area without structural augmentation or volumising correction. The formulation is based on polynucleotides (PN), which are widely incorporated into aesthetic protocols focused on tissue conditioning and skin support. Within clinical practice, polynucleotide injectables are selected for areas requiring careful product placement due to anatomical sensitivity and skin fragility. AMI Eyes is commonly used in patients presenting with concerns such as reduced skin quality, fine surface lines, and general under-eye skin fatigue. It is intended to integrate into structured, practitioner-led treatment plans where gradual and controlled improvement is prioritised over immediate correction. Due to the anatomical complexity of the periocular region, this product is intended for administration only by trained medical professionals with experience in under-eye injectable techniques. It may be used as a standalone protocol or incorporated into broader skin quality treatment planning. How It Works AMI Eyes is administered into the superficial layers of the periocular skin. The polynucleotide-based formulation works within the dermal environment to support hydration and skin conditioning. Polynucleotides are commonly used in aesthetic medicine to assist the skin’s natural renewal processes. When delivered as part of a structured treatment plan, the formulation supports gradual improvement in overall skin quality in the treated area. It is not designed to add volume or alter facial structure. Key Benefits • Supports hydration in the periocular region • Helps improve overall under-eye skin quality • Designed specifically for delicate eye-area skin • Non-volumising injectable approach • Suitable for staged professional treatment protocols